Temat: "Schizophrenia" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy study.
Autorzy:: Torres-Carmona E; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Nakajima S; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Neuropsychiatry, Keio University, Minato, Tokyo, Japan.
Iwata Y; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Ueno F; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Stefan C; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Song J; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Abdolizadeh A; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Koizumi MT; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Kambari Y; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Amaev A; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Agarwal SM; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Family Mental Health Research Institute, CAMH, Toronto, ON, Canada.
Mar W; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
de Luca V; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Family Mental Health Research Institute, CAMH, Toronto, ON, Canada.
Remington G; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Family Mental Health Research Institute, CAMH, Toronto, ON, Canada.
Gerretsen P; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Family Mental Health Research Institute, CAMH, Toronto, ON, Canada.
Graff-Guerrero A; Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Family Mental Health Research Institute, CAMH, Toronto, ON, Canada. Electronic address: .; Pokaż więcej
Źródło:: Schizophrenia research [Schizophr Res] 2024 Aug; Vol. 270, pp. 152-161. Date of Electronic Publication: 2024 Jun 22.
Typ publikacji:: Journal Article
MeSH Terms:: Clozapine*/pharmacology
Astrocytes*/drug effects
Astrocytes*/metabolism
Astrocytes*/pathology
Antipsychotic Agents*/pharmacology
Proton Magnetic Resonance Spectroscopy*
Schizophrenia, Treatment-Resistant*/drug therapy
Schizophrenia, Treatment-Resistant*/metabolism
Humans ; Adult ; Male ; Female ; Middle Aged ; Inositol/metabolism ; Schizophrenia/drug therapy ; Schizophrenia/metabolism ; Schizophrenia/diagnostic imaging ; Schizophrenia/pathology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 2.

Tytuł:: Predicting treatment resistance in schizophrenia patients: Machine learning highlights the role of early pathophysiologic features.
Autorzy:: Barruel D; GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, 1, rue Cabanis, 75014 Paris, France. Electronic address: .
Hilbey J; Sorbonne Université, Paris, France; Laboratoire d'Informatique Médicale et d'Ingénierie des Connaissances en e-Santé, LIMICS, Paris, France.
Charlet J; Laboratoire d'Informatique Médicale et d'Ingénierie des Connaissances en e-Santé, LIMICS, Paris, France; Assistance Publique-Hôpitaux de Paris, Paris, France.
Chaumette B; GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, 1, rue Cabanis, 75014 Paris, France; Université de Paris, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM, U1266 Paris, France; Department of Psychiatry, McGill University, Montréal, QC, Canada.
Krebs MO; GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, 1, rue Cabanis, 75014 Paris, France; Université de Paris, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM, U1266 Paris, France.
Dauriac-Le Masson V; GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, 1, rue Cabanis, 75014 Paris, France.; Pokaż więcej
Źródło:: Schizophrenia research [Schizophr Res] 2024 Aug; Vol. 270, pp. 1-10. Date of Electronic Publication: 2024 May 31.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Machine Learning*
Schizophrenia, Treatment-Resistant*/drug therapy
Schizophrenia, Treatment-Resistant*/physiopathology
Humans ; Male ; Female ; Adult ; Retrospective Studies ; Antipsychotic Agents/pharmacology ; Risk Factors ; Young Adult ; Middle Aged ; Medication Adherence ; Adolescent ; Prognosis ; Schizophrenia/drug therapy ; Schizophrenia/physiopathology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 3.

Tytuł:: Elevated intrinsic cortical curvature in treatment-resistant schizophrenia: Evidence of structural deformation in functional connectivity areas and comparison with alternate indices of structure.
Autorzy:: Torres-Carmona E; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Ueno F; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Iwata Y; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Neuropsychiatry, Keio University, Minato, Tokyo, Japan.
Nakajima S; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Neuropsychiatry, Keio University, Minato, Tokyo, Japan.
Song J; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Mar W; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Abdolizadeh A; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Agarwal SM; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Institute Research Program, CAMH, Toronto, ON, Canada.
de Luca V; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Institute Research Program, CAMH, Toronto, ON, Canada.
Remington G; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Institute Research Program, CAMH, Toronto, ON, Canada.
Gerretsen P; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Institute Research Program, CAMH, Toronto, ON, Canada.
Graff-Guerrero A; Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Campbell Institute Research Program, CAMH, Toronto, ON, Canada. Electronic address: .; Pokaż więcej
Źródło:: Schizophrenia research [Schizophr Res] 2024 Jul; Vol. 269, pp. 103-113. Date of Electronic Publication: 2024 May 18.
Typ publikacji:: Journal Article
MeSH Terms:: Magnetic Resonance Imaging*
Antipsychotic Agents*/pharmacology
Clozapine*/pharmacology
Cerebral Cortex*/diagnostic imaging
Cerebral Cortex*/pathology
Cerebral Cortex*/drug effects
Cerebral Cortex*/physiopathology
Schizophrenia, Treatment-Resistant*/drug therapy
Schizophrenia, Treatment-Resistant*/pathology
Schizophrenia, Treatment-Resistant*/physiopathology
Schizophrenia, Treatment-Resistant*/diagnostic imaging
Humans ; Female ; Male ; Adult ; Middle Aged ; Young Adult ; Schizophrenia/drug therapy ; Schizophrenia/diagnostic imaging ; Schizophrenia/physiopathology ; Schizophrenia/pathology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 4.

Tytuł:: The role of control groups in non-pharmacological randomised controlled trials of treatment-resistant schizophrenia: A systematic review and meta-analysis.
Autorzy:: Schütz A; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Munich, Germany.
Salahuddin NH; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Munich, Germany.
Priller J; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Munich, Germany; German Center for Mental Health (DZPG), Germany; Neuropsychiatry, Charité - Universitätsmedizin Berlin and DZNE Berlin, Charitéplatz 1, 10117 Berlin, Germany; University of Edinburgh and UK DRI, 49 Little France Cres, Edinburgh EH16 4SB, UK.
Bighelli I; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Munich, Germany; German Center for Mental Health (DZPG), Germany.
Leucht S; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Munich, Germany; German Center for Mental Health (DZPG), Germany. Electronic address: .; Pokaż więcej
Źródło:: Psychiatry research [Psychiatry Res] 2024 Sep; Vol. 339, pp. 116069. Date of Electronic Publication: 2024 Jul 06.
Typ publikacji:: Systematic Review; Journal Article; Meta-Analysis; Review
MeSH Terms:: Randomized Controlled Trials as Topic*
Control Groups*
Schizophrenia, Treatment-Resistant*/therapy
Humans ; Psychosocial Intervention/methods ; Outcome Assessment, Health Care ; Schizophrenia/therapy

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 5.

Tytuł:: A history of childhood schizophrenia and lessons for autism.
Autorzy:: Fellowes S; Department of Politics, Philosophy and Religion, County South, Lancaster University, Lancaster, LA1 4YL, UK. .; Pokaż więcej
Źródło:: History and philosophy of the life sciences [Hist Philos Life Sci] 2024 Aug 12; Vol. 46 (3), pp. 29. Date of Electronic Publication: 2024 Aug 12.
Typ publikacji:: Journal Article; Historical Article
MeSH Terms:: Schizophrenia, Childhood*/history
History, 20th Century ; Humans ; Autistic Disorder/history ; Autistic Disorder/etiology ; Child ; United States ; Schizophrenia/history ; Schizophrenia/etiology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 6.

Tytuł:: Role of electroconvulsive therapy in patients with clozapine-refractory schizophrenia.
Autorzy:: Markota M; Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: .
Croarkin PE; Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Gentry MT; Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Leung JG; Department of Pharmacy, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.; Pokaż więcej
Źródło:: Schizophrenia research [Schizophr Res] 2024 Jul; Vol. 269, pp. 130-131. Date of Electronic Publication: 2024 May 21.
Typ publikacji:: Letter
MeSH Terms:: Electroconvulsive Therapy*
Clozapine*/therapeutic use
Antipsychotic Agents*
Schizophrenia, Treatment-Resistant*/drug therapy
Schizophrenia, Treatment-Resistant*/therapy
Humans ; Adult ; Male ; Female ; Middle Aged ; Schizophrenia/drug therapy ; Schizophrenia/therapy

Opinia redakcyjna

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 7.

Tytuł:: Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy.
Autorzy:: Martini F; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Spangaro M; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, Milan, Italy. .
Bechi M; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Agostoni G; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Buonocore M; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Sapienza J; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Department of Humanities and Life Sciences, University School for Advanced Studies IUSS, Pavia, Italy.
Nocera D; Vita-Salute San Raffaele University, Milan, Italy.
Ave C; Vita-Salute San Raffaele University, Milan, Italy.
Cocchi F; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Cavallaro R; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.
Bosia M; Department of Clinical Neurosciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.; Pokaż więcej
Źródło:: European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2024 Sep; Vol. 274 (6), pp. 1473-1481. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:: Journal Article
MeSH Terms:: Cognitive Remediation*
Cognitive Dysfunction*/etiology
Cognitive Dysfunction*/therapy
Cognitive Dysfunction*/rehabilitation
Cognitive Dysfunction*/physiopathology
Schizophrenia, Treatment-Resistant*/therapy
Humans ; Male ; Female ; Adult ; Middle Aged ; Outcome Assessment, Health Care ; Executive Function/physiology ; Antipsychotic Agents ; Neuropsychological Tests ; Schizophrenia/therapy ; Schizophrenia/physiopathology ; Schizophrenia/complications

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 8.

Tytuł:: Negative symptoms in treatment-resistant schizophrenia and its relationship with functioning.
Autorzy:: Lui SSY; Department of Psychiatry, School of Clinical Medicine, The Unversity of Hong Kong, Hong Kong SAR, China. Electronic address: .
Lam EHY; Castle Peak Hospital, Hong Kong.
Wang LL; Neuropsychology and Applied Cognitive Neuroscience Laboratory, CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China; School of Psychology, Shanghai Normal University, Shanghai, China.
Leung PBM; Department of Psychiatry, School of Clinical Medicine, The Unversity of Hong Kong, Hong Kong SAR, China.
Cheung ESL; Department of Psychiatry, School of Clinical Medicine, The Unversity of Hong Kong, Hong Kong SAR, China.
Wong CHY; Department of Psychiatry, School of Clinical Medicine, The Unversity of Hong Kong, Hong Kong SAR, China.
Zhan N; Department of Psychiatry, School of Clinical Medicine, The Unversity of Hong Kong, Hong Kong SAR, China.
Wong RWK; Department of Psychiatry, School of Clinical Medicine, The Unversity of Hong Kong, Hong Kong SAR, China.
Siu BWM; Castle Peak Hospital, Hong Kong.
Tang DYY; Castle Peak Hospital, Hong Kong.
Liu ACY; Castle Peak Hospital, Hong Kong.
Chan RCK; Neuropsychology and Applied Cognitive Neuroscience Laboratory, CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China. Electronic address: .; Pokaż więcej
Źródło:: Schizophrenia research [Schizophr Res] 2024 Aug; Vol. 270, pp. 459-464. Date of Electronic Publication: 2024 Jul 13.
Typ publikacji:: Journal Article
MeSH Terms:: Schizophrenia, Treatment-Resistant*/physiopathology
Humans ; Female ; Male ; Adult ; Middle Aged ; Cluster Analysis ; Psychiatric Status Rating Scales ; Schizophrenic Psychology ; Psychosocial Functioning ; Schizophrenia/physiopathology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 9.

Tytuł:: Evaluation of the pharmacodynamic interaction effect of augmentation agents with clozapine in patients with treatment-resistant schizophrenia: A simulation study of clinical data.
Autorzy:: Mishra A; Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar 751019, India.
Maiti R; Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar 751019, India.
Ramasubbu MK; Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar 751019, India.
Srinivasan A; Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar 751019, India. Electronic address: .; Pokaż więcej
Źródło:: Psychiatry research [Psychiatry Res] 2024 Aug; Vol. 338, pp. 115989. Date of Electronic Publication: 2024 Jun 01.
Typ publikacji:: Journal Article
MeSH Terms:: Clozapine*/pharmacology
Clozapine*/therapeutic use
Antipsychotic Agents*/pharmacology
Drug Therapy, Combination*
Schizophrenia, Treatment-Resistant*/drug therapy
Humans ; Adult ; Male ; Female ; Computer Simulation ; Drug Interactions ; Drug Synergism ; Middle Aged ; Schizophrenia/drug therapy ; Risperidone/pharmacology ; Risperidone/therapeutic use ; Piperazines ; Thiazoles

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 10.

Tytuł:: Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice.
Autorzy:: Agid O; Centre for Addiction and Mental Health, University of Toronto, Canada.
Crespo-Facorro B; Department of Psychiatry, School of Medicine, University Hospital Virgen del Rocío-IBiS-CSIC, Sevilla, Spain, Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Sevilla, Spain.
de Bartolomeis A; University of Naples Federico II, Department of Neuroscience, Reproductive Science, and Odontostomatology. Laboratory of Molecular and Translational Psychiatry. Unit of Treatment Resistant Psychosis, Naples, Italy; Staff Unesco Chair at University of Naples Federico II, Italy.
Fagiolini A; University of Siena, Siena, Italy.
Howes OD; IoPPN, King's College London, De Crespigny Park, London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London, United Kingdom.
Seppälä N; Wellbeing Services in Satakunta, Department of Psychiatry, Pori, Finland and Medical Consultant, Viatris, Finland.
Correll CU; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, New York, United States; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, New York, United States; Charité - Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Augustenburger Platz 1, Berlin 13353, Germany; German Center for Mental Health (DZPG), Partner Site Berlin, Berlin, Germany. Electronic address: .; Pokaż więcej
Źródło:: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2024 Jul; Vol. 84, pp. 35-47. Date of Electronic Publication: 2024 Apr 23.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Clozapine*/therapeutic use
Clozapine*/adverse effects
Antipsychotic Agents*/therapeutic use
Antipsychotic Agents*/adverse effects
Schizophrenia, Treatment-Resistant*/drug therapy
Humans ; Health Services Accessibility ; Schizophrenia/drug therapy

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 11.

Tytuł:: Identification and treatment of individuals with childhood-onset and early-onset schizophrenia.
Autorzy:: Correll CU; Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; Department of Psychiatry, Zucker Hillside Hospital, Northwell Health System, Glen Oaks, NY, USA. Electronic address: .
Arango C; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense, Madrid, Spain.
Fagerlund B; Child and Adolescent Mental Health Center, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark; Department of Psychology, Faculty of Social Sciences, University of Copenhagen, Copenhagen, Denmark.
Galderisi S; Department of Mental and Physical Health and Preventive Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Kas MJ; Groningen Institute for Evolutionary Life Sciences (GELIFES), Neurobiology, University of Groningen, the Netherlands.
Leucht S; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Germany; Department of Psychiatry, Department of Psychosis Studies, and Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.; Pokaż więcej
Źródło:: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2024 May; Vol. 82, pp. 57-71. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Age of Onset*
Antipsychotic Agents*/therapeutic use
Antipsychotic Agents*/adverse effects
Schizophrenia*/diagnosis
Schizophrenia*/therapy
Schizophrenia*/drug therapy
Schizophrenia*/epidemiology
Humans ; Child ; Adolescent ; Schizophrenia, Childhood/diagnosis ; Schizophrenia, Childhood/therapy ; Early Diagnosis

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 12.

Tytuł:: Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia.
Autorzy:: Melzer-Ribeiro DL; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
Napolitano IC; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
Leite SA; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
Alencar de Souza JA; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
Vizzotto ADB; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
Di Sarno ES; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
Fortes M; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
Gomes ML; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
de Oliveira GM; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
Avrichir BS; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
Talib LL; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil.
Correll CU; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; Charité - Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany.
Elkis H; Department and Institute of Psychiatry, University of São Paulo Medical School (FMUSP), Brazil. Electronic address: .; Pokaż więcej
Źródło:: Schizophrenia research [Schizophr Res] 2024 Jun; Vol. 268, pp. 252-260. Date of Electronic Publication: 2023 Dec 26.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Electroconvulsive Therapy*/adverse effects
Clozapine*/therapeutic use
Clozapine*/adverse effects
Antipsychotic Agents*/therapeutic use
Schizophrenia, Treatment-Resistant*/therapy
Schizophrenia, Treatment-Resistant*/drug therapy
Humans ; Male ; Female ; Adult ; Double-Blind Method ; Middle Aged ; Psychiatric Status Rating Scales ; Treatment Outcome ; Schizophrenia/therapy ; Schizophrenia/drug therapy ; Outcome Assessment, Health Care

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 13.

Tytuł:: Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia.
Autorzy:: He J; Department of Psychiatry, Sir Run-Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.
Li J; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.; Affiliated Wuhan Mental Health Center, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wei Y; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.; Department of Psychiatry, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
He Z; Department of Psychiatry, Sir Run-Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.; School of Mental Health, Wenzhou Medical University, Wenzhou, China.
Liu J; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.; Xiangya Nursing School of Central South University, Changsha, China.
Yuan N; Hunan Provincial Brain Hospital (The second people's Hospital of Hunan Province), Changsha, China.
Zhou R; The Ninth Hospital of Changsha, Changsha, China.
He X; The Ninth Hospital of Changsha, Changsha, China.
Ren H; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.; Department of Psychiatry, Shandong Provincial Hospital, Shandong University, Jinan, China.
Gu L; RIKEN Center for Advanced Intelligence Project, Tokyo, Japan.; Research Center for Advanced Science and Technology (RCAST), University of Tokyo, Tokyo, Japan.
Liao Y; Department of Psychiatry, Sir Run-Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Chen X; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China. .
Tang J; Department of Psychiatry, Sir Run-Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China. .; Hunan Provincial Brain Hospital (The second people's Hospital of Hunan Province), Changsha, China. .; Zigong Mental Health Center, Zigong, China. .; Pokaż więcej
Źródło:: BMC psychiatry [BMC Psychiatry] 2024 Apr 02; Vol. 24 (1), pp. 248. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Clozapine*/adverse effects
Schizophrenia*/drug therapy
Schizophrenia*/diagnosis
Antipsychotic Agents*/adverse effects
Humans ; Schizophrenia, Treatment-Resistant ; Receptors, Glutamate/therapeutic use ; Glutamic Acid

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Clozapine in treatment-resistant schizophrenia: Reflections from the Hallmark US clinical trial and beyond.
Autorzy:: Kane JM; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA.
Schoretsanitis G; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA; Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland. Electronic address: .
Rubio JM; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA.
Correll CU; The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany; German Center for Mental Health (DZPG), partner site Berlin, Germany.; Pokaż więcej
Źródło:: Schizophrenia research [Schizophr Res] 2024 Jun; Vol. 268, pp. 9-13. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:: Letter; Journal Article
MeSH Terms:: Clozapine*/therapeutic use
Antipsychotic Agents*/therapeutic use
Antipsychotic Agents*/pharmacology
Schizophrenia, Treatment-Resistant*/drug therapy
Humans ; United States ; Schizophrenia/drug therapy

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 15.

Tytuł:: A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia.
Autorzy:: Cheuk NKW; Department of Psychiatry, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China.
Tse W; Department of Psychiatry, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China.
Tsui HKH; Department of Psychiatry, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China.
Ma CF; Department of Psychiatry, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China; School of Nursing, The Hong Kong Polytechnic University, China.
Chun JSW; Department of Psychiatry, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China.
Chung AKK; Department of Psychiatry, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China.
Chan SKW; Department of Psychiatry, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China; The State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, China. Electronic address: .; Pokaż więcej
Źródło:: Schizophrenia research [Schizophr Res] 2024 Jun; Vol. 268, pp. 205-222. Date of Electronic Publication: 2023 Oct 01.
Typ publikacji:: Systematic Review; Journal Article; Meta-Analysis
MeSH Terms:: Clozapine*
Antipsychotic Agents*/administration & dosage
Antipsychotic Agents*/pharmacology
Schizophrenia, Treatment-Resistant*/drug therapy
Humans ; Cognitive Dysfunction/etiology ; Cognitive Dysfunction/chemically induced ; Cognitive Dysfunction/physiopathology ; Schizophrenia/drug therapy ; Cognition/drug effects

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 16.

Tytuł:: A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia.
Autorzy:: Dong S; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaningerstr. 22, 81675, Munich, Germany.
Schneider-Thoma J; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaningerstr. 22, 81675, Munich, Germany.
Bighelli I; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaningerstr. 22, 81675, Munich, Germany.
Siafis S; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaningerstr. 22, 81675, Munich, Germany.
Wang D; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaningerstr. 22, 81675, Munich, Germany.
Burschinski A; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaningerstr. 22, 81675, Munich, Germany.
Schestag K; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaningerstr. 22, 81675, Munich, Germany.
Samara M; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaningerstr. 22, 81675, Munich, Germany.; Department of Psychiatry, Faculty of Medicine, University of Thessaly, Larisa, Greece.
Leucht S; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaningerstr. 22, 81675, Munich, Germany. .; Pokaż więcej
Źródło:: European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2024 Jun; Vol. 274 (4), pp. 917-928. Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Antipsychotic Agents*/adverse effects
Antipsychotic Agents*/administration & dosage
Network Meta-Analysis*
Schizophrenia, Treatment-Resistant*/drug therapy
Humans ; Outcome Assessment, Health Care ; Clozapine/adverse effects ; Schizophrenia/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Response to the letter to the Editor from Araujo and colleagues on the research article entitled, "Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study".
Autorzy:: Tsukahara M; Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan.
So R; Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan.
Yoshimura Y; Department of Psychiatry, Ajino Clinic, Okayama, Japan.
Nakajima S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Takeuchi H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Pokaż więcej
Źródło:: Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2024 May; Vol. 149 (5), pp. 436-438. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:: Letter; Comment
MeSH Terms:: Clozapine*/therapeutic use
Schizophrenia*/drug therapy
Schizophrenia*/chemically induced
Antipsychotic Agents*/therapeutic use
Humans ; Valproic Acid/pharmacology ; Valproic Acid/therapeutic use ; Smoking ; Schizophrenia, Treatment-Resistant ; Retrospective Studies ; Chronic Disease ; Recurrence ; Habits

Opinia redakcyjna

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 18.

Tytuł:: Non-invasive brain stimulation for treatment-resistant schizophrenia: protocol of a systematic review and network meta-analysis.
Autorzy:: Siafis S; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany. .
Lorenz C; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany.
Wu H; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany.
Zhu Y; Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Schneider-Thoma J; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany.
Bighelli I; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany.
Li C; Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Institute of Psychology and Behavioral Science, Shanghai Jiao Tong University, Shanghai, China.
Hansen WP; BASTA-Das Bündnis Für Psychisch Erkrankte Menschen, Munich, Germany.
Padberg F; Department of Psychiatry and Psychotherapy, LMU University Hospital Munich, Munich, Germany.
Salanti G; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Leucht S; Technical University of Munich, TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy, Munich, Germany.; Pokaż więcej
Źródło:: Systematic reviews [Syst Rev] 2024 Jun 24; Vol. 13 (1), pp. 165. Date of Electronic Publication: 2024 Jun 24.
Typ publikacji:: Journal Article
MeSH Terms:: Systematic Reviews as Topic*
Network Meta-Analysis*
Schizophrenia, Treatment-Resistant*/therapy
Transcranial Direct Current Stimulation*/methods
Humans ; Antipsychotic Agents/therapeutic use ; Transcranial Magnetic Stimulation/methods ; Meta-Analysis as Topic ; Randomized Controlled Trials as Topic ; Schizophrenia/therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Clozapine in treatment-resistant schizophrenia: Who designed that famous US clinical trial?
Autorzy:: Honigfeld G; Department of Psychology, William Paterson University, Wayne, NJ, USA. Electronic address: .; Pokaż więcej
Źródło:: Schizophrenia research [Schizophr Res] 2024 Jun; Vol. 268, pp. 7-8. Date of Electronic Publication: 2023 Aug 31.
Typ publikacji:: Journal Article
MeSH Terms:: Clozapine*/therapeutic use
Antipsychotic Agents*/therapeutic use
Schizophrenia, Treatment-Resistant*/drug therapy
Humans ; United States ; Clinical Trials as Topic ; Schizophrenia/drug therapy

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 20.

Tytuł:: Insights and improvements: A critical analysis of methodological limitations in the investigation of smoking and valproic acid in treatment-resistant schizophrenia.
Autorzy:: Araujo MB; School of Medicine, Federal University of Ceara, Fortaleza, Ceará, Brazil.
Nogueira GN; School of Medicine, Federal University of Ceara, Fortaleza, Ceará, Brazil.
Silveira PLSD; School of Medicine, Federal University of Ceara, Fortaleza, Ceará, Brazil.
de Souza Júnior SA; University Hospital Walter Cantidio, Federal University of Ceara, Fortaleza, Ceará, Brazil.
de Matos E Souza FG; Psychiatric Service, University Hospital Walter Cantidio, Fortaleza, Ceará, Brazil.; Clinical Medicine Department, Federal University of Ceara, Fortaleza, Ceará, Brazil.
Bisol LW; Psychiatric Service, University Hospital Walter Cantidio, Fortaleza, Ceará, Brazil.; Clinical Medicine Department, Federal University of Ceara, Fortaleza, Ceará, Brazil.; Pokaż więcej
Źródło:: Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2024 Apr; Vol. 149 (4), pp. 361-362. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:: Letter; Comment
MeSH Terms:: Schizophrenia*/drug therapy
Antipsychotic Agents*/therapeutic use
Humans ; Valproic Acid/therapeutic use ; Schizophrenia, Treatment-Resistant ; Smoking

Opinia redakcyjna

na półce

Full Text Finder Szczegóły

Informacja

Wyszukujesz frazę ""Schizophrenia"" wg kryterium: Temat

Starter badań:

Schizophrenia.